Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

Clinical trial NCT00697684 · COMPLETED

Trial details

NCT number: NCT00697684
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome Acute Lymphocytic Leukemia Relapsed/Refractory Chronic Lymphocytic Leukemia Relapsed/Refractory Non Hodgkin's Lymphoma Hodgkins Disease Relapsed Refractory Multiple Myeloma

Start date: 2008-06-01
Primary completion: 2020-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.